James D. Nash

1.9k total citations
24 papers, 1.4k citations indexed

About

James D. Nash is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, James D. Nash has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in Infectious Diseases. Recurrent topics in James D. Nash's work include Innovations in Medical Education (3 papers), Streptococcal Infections and Treatments (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). James D. Nash is often cited by papers focused on Innovations in Medical Education (3 papers), Streptococcal Infections and Treatments (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). James D. Nash collaborates with scholars based in United States, United Kingdom and France. James D. Nash's co-authors include Paddy Farrington, E. Kathryn Miller, Emma R. Miller, Simon Pugh, A. J. E. Flower, A. Colville, Karen Busenbark, William C. Koller, Thomas J. Marrie and Pierre‐Edouard Fournier and has published in prestigious journals such as The Lancet, Neurology and American Journal of Epidemiology.

In The Last Decade

James D. Nash

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James D. Nash United States 13 493 375 292 288 232 24 1.4k
Thomas Weinke Germany 19 900 1.8× 416 1.1× 250 0.9× 395 1.4× 92 0.4× 49 1.7k
Maria Theodoridou Greece 25 598 1.2× 333 0.9× 51 0.2× 515 1.8× 30 0.1× 69 1.9k
Jorge Salinas United States 19 237 0.5× 450 1.2× 58 0.2× 289 1.0× 56 0.2× 100 1.1k
Peter N.R. Heseltine United States 24 652 1.3× 416 1.1× 191 0.7× 168 0.6× 23 0.1× 71 1.7k
J. Gaillat France 15 568 1.2× 170 0.5× 78 0.3× 41 0.1× 166 0.7× 49 837
Sheila F. O’Brien Canada 27 838 1.7× 762 2.0× 102 0.3× 438 1.5× 75 0.3× 186 2.6k
Vitali Pool United States 16 489 1.0× 529 1.4× 20 0.1× 154 0.5× 319 1.4× 31 1.5k
Christina Y. Chan United States 18 873 1.8× 156 0.4× 171 0.6× 60 0.2× 66 0.3× 31 1.5k
F. Y. Aoki Canada 20 1.5k 3.0× 399 1.1× 53 0.2× 118 0.4× 59 0.3× 41 1.8k
Norbert A. Foudraine Netherlands 22 635 1.3× 1.0k 2.8× 64 0.2× 110 0.4× 81 0.3× 47 2.0k

Countries citing papers authored by James D. Nash

Since Specialization
Citations

This map shows the geographic impact of James D. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Nash more than expected).

Fields of papers citing papers by James D. Nash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Nash. The network helps show where James D. Nash may publish in the future.

Co-authorship network of co-authors of James D. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Nash. A scholar is included among the top collaborators of James D. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Nash. James D. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domina, Aaron M., et al.. (2024). Implementing Restorative Justice Training: A Pathway to Enhanced Communication and Conflict Resolution. American Journal of Pharmaceutical Education. 88(9). 101166–101166.
2.
Nash, James D., et al.. (2018). Healthy People 2020: assessment of pharmacists' priorities. Public Health. 155. 69–80. 5 indexed citations
3.
Nash, James D., et al.. (2017). Revisiting the Promise and Foundations of a Jesuit Education. ePublications at Regis University (Regis University). 6(1). 10. 1 indexed citations
4.
Mota, Paula, et al.. (2017). Pneumococcal pulmonary valve endocarditis. Echo Research and Practice. 4(3). K1–K5. 4 indexed citations
5.
Wilson, Laura, et al.. (2013). IPads in Elementary Education: Content Mastery and Curriculum Pacing.. Society for Information Technology & Teacher Education International Conference. 2013(1). 3810–3813. 1 indexed citations
6.
Borja‐Hart, Nancy, et al.. (2013). The Prevalence and Characteristics of Dual PharmD/MPH Programs Offered at US Colleges and Schools of Pharmacy. American Journal of Pharmaceutical Education. 77(6). 116–116. 11 indexed citations
7.
Gilligan, Adrienne M., James D. Nash, Jill E. Lavigne, et al.. (2012). Educating Pharmacy Students to Improve Quality (EPIQ) in Colleges and Schools of Pharmacy. American Journal of Pharmaceutical Education. 76(6). 109–109. 16 indexed citations
8.
Shalchi, Zaid, Avinash Gurbaxani, Mark E. Baker, & James D. Nash. (2011). Antibiotic Resistance in Microbial Keratitis: Ten-Year Experience of Corneal Scrapes in the United Kingdom. Ophthalmology. 118(11). 2161–2165. 91 indexed citations
9.
Hill, Robert L., Angela Kearns, James D. Nash, et al.. (2010). Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 65(3). 442–445. 52 indexed citations
10.
Shalchi, Zaid, Alex Bennett, David Hargroves, & James D. Nash. (2009). Diagnostic delay in a case of herpes simplex encephalitis. BMJ Case Reports. 2009. bcr1220081350–bcr1220081350. 6 indexed citations
11.
12.
Olson, Kari L., et al.. (2006). Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. American Journal of Health-System Pharmacy. 64(1). 77–84. 26 indexed citations
13.
Saeed, Muhammad Usman, et al.. (2004). An unusual pathogen causing microbial keratitis. Acta Ophthalmologica Scandinavica. 82(5). 606–608. 3 indexed citations
14.
Raoult, Didier, Pierre‐Edouard Fournier, François Vandenesch, et al.. (2003). Outcome and Treatment of Bartonella Endocarditis. Archives of Internal Medicine. 163(2). 226–226. 165 indexed citations
15.
Fournier, Pierre‐Edouard, Hervé Lelièvre, Susannah Eykyn, et al.. (2001). Epidemiologic and Clinical Characteristics of Bartonella quintana and Bartonella henselae Endocarditis. Medicine. 80(4). 245–251. 172 indexed citations
16.
Farrington, Paddy, James D. Nash, & E. Kathryn Miller. (1996). Case Series Analysis of Adverse Reactions to Vaccines: A Comparative Evaluation. American Journal of Epidemiology. 143(11). 1165–1173. 163 indexed citations
17.
Farrington, Paddy, M Rush, Emma R. Miller, et al.. (1995). A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. The Lancet. 345(8949). 567–569. 242 indexed citations
18.
Miller, Emma R., Paddy Farrington, Simon Pugh, et al.. (1993). Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children. The Lancet. 341(8851). 979–982. 138 indexed citations
19.
Koller, William C., et al.. (1990). Sexual Dysfunction in Parkinsonʼs Disease. Clinical Neuropharmacology. 13(5). 461–463. 70 indexed citations
20.
Nash, James D. & Lawrence H. Schwartz. (1987). Computers and the writing process. 5(1). 45–48. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Weinke Breakdown of academic impact, for papers by Maria Theodoridou Breakdown of academic impact, for papers by Jorge Salinas Breakdown of academic impact, for papers by Peter N.R. Heseltine Breakdown of academic impact, for papers by J. Gaillat Breakdown of academic impact, for papers by Sheila F. O’Brien Breakdown of academic impact, for papers by Vitali Pool Breakdown of academic impact, for papers by Christina Y. Chan Breakdown of academic impact, for papers by F. Y. Aoki Breakdown of academic impact, for papers by Norbert A. Foudraine
Rankless by CCL
2026